Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.
Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness ...
Francer is Lilly’s vice president, head of global regulatory policy and strategy. Cruz is Lilly’s senior vice president, ...
Fluor is set to gain from U.S. pharma reshoring and rising sector investment, with strong fundamentals and value. Learn why ...
HOUSTON — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to build a new $6.5 billion manufacturing facility at Generation ...
President Trump’s new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply chain, with experts calling for more clarity and details into the ...
With growing demand for advanced therapies, improved manufacturing processes are needed to provide flexibility and increase ...
In a Truth Social post, Trump noted that the White House would place a 100% tariff on “any branded or patented” pharmaceutical product — unless a company was investing in manufacturing facilities in ...
AbbVie (ABBV) announced the start of construction of its new active pharmaceutical ingredient manufacturing plant in North ...
President Donald Trump says 100% tariffs on certain pharmaceuticals will take effect next week, but there are several ...
“The idea to process drugs in space isn’t new. Research showing that microgravity can impact crystallization has been done on ...
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results